| UniProt ID | TM9S3_HUMAN | |
|---|---|---|
| UniProt AC | Q9HD45 | |
| Protein Name | Transmembrane 9 superfamily member 3 | |
| Gene Name | TM9SF3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 589 | |
| Subcellular Localization |
Membrane Multi-pass membrane protein . |
|
| Protein Description | ||
| Protein Sequence | MRPLPGALGVAAAAALWLLLLLLPRTRADEHEHTYQDKEEVVLWMNTVGPYHNRQETYKYFSLPFCVGSKKSISHYHETLGEALQGVELEFSGLDIKFKDDVMPATYCEIDLDKEKRDAFVYAIKNHYWYQMYIDDLPIWGIVGEADENGEDYYLWTYKKLEIGFNGNRIVDVNLTSEGKVKLVPNTKIQMSYSVKWKKSDVKFEDRFDKYLDPSFFQHRIHWFSIFNSFMMVIFLVGLVSMILMRTLRKDYARYSKEEEMDDMDRDLGDEYGWKQVHGDVFRPSSHPLIFSSLIGSGCQIFAVSLIVIIVAMIEDLYTERGSMLSTAIFVYAATSPVNGYFGGSLYARQGGRRWIKQMFIGAFLIPAMVCGTAFFINFIAIYYHASRAIPFGTMVAVCCICFFVILPLNLVGTILGRNLSGQPNFPCRVNAVPRPIPEKKWFMEPAVIVCLGGILPFGSIFIEMYFIFTSFWAYKIYYVYGFMMLVLVILCIVTVCVTIVCTYFLLNAEDYRWQWTSFLSAASTAIYVYMYSFYYYFFKTKMYGLFQTSFYFGYMAVFSTALGIMCGAIGYMGTSAFVRKIYTNVKID | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 47 | Phosphorylation | EVVLWMNTVGPYHNR HEEEEEECCCCCCCC | 15.67 | 23663014 | |
| 51 | Phosphorylation | WMNTVGPYHNRQETY EEECCCCCCCCHHHC | 13.05 | 23663014 | |
| 57 | Phosphorylation | PYHNRQETYKYFSLP CCCCCHHHCEEEECC | 19.58 | 23663014 | |
| 59 | Ubiquitination | HNRQETYKYFSLPFC CCCHHHCEEEECCEE | 47.44 | 21890473 | |
| 59 | Ubiquitination | HNRQETYKYFSLPFC CCCHHHCEEEECCEE | 47.44 | 21890473 | |
| 70 | Acetylation | LPFCVGSKKSISHYH CCEECCCCCCHHHHH | 44.61 | 26051181 | |
| 71 | Ubiquitination | PFCVGSKKSISHYHE CEECCCCCCHHHHHH | 55.51 | - | |
| 116 | 2-Hydroxyisobutyrylation | EIDLDKEKRDAFVYA EEECCHHHHHHHEEE | 62.41 | - | |
| 122 | Phosphorylation | EKRDAFVYAIKNHYW HHHHHHEEEECCCEE | 8.99 | - | |
| 128 | Phosphorylation | VYAIKNHYWYQMYID EEEECCCEEEEEEEC | 18.40 | 23401153 | |
| 130 | Phosphorylation | AIKNHYWYQMYIDDL EECCCEEEEEEECCC | 4.00 | 23401153 | |
| 133 | Phosphorylation | NHYWYQMYIDDLPIW CCEEEEEEECCCCEE | 5.91 | 23401153 | |
| 153 | Phosphorylation | ADENGEDYYLWTYKK CCCCCCEEEEEEEEE | 8.99 | 23401153 | |
| 154 | Phosphorylation | DENGEDYYLWTYKKL CCCCCEEEEEEEEEE | 14.21 | 23401153 | |
| 157 | Phosphorylation | GEDYYLWTYKKLEIG CCEEEEEEEEEEEEC | 23.91 | 23401153 | |
| 160 | Ubiquitination | YYLWTYKKLEIGFNG EEEEEEEEEEECCCC | 40.72 | - | |
| 174 | N-linked_Glycosylation | GNRIVDVNLTSEGKV CCEEEEEEECCCCEE | 32.89 | 17660510 | |
| 174 | N-linked_Glycosylation | GNRIVDVNLTSEGKV CCEEEEEEECCCCEE | 32.89 | 19349973 | |
| 182 | Ubiquitination | LTSEGKVKLVPNTKI ECCCCEEEECCCCEE | 47.45 | - | |
| 196 | Acetylation | IQMSYSVKWKKSDVK EEEEEEEEEECCCCC | 47.56 | 24885463 | |
| 198 | Acetylation | MSYSVKWKKSDVKFE EEEEEEEECCCCCHH | 36.36 | 28641951 | |
| 203 | Ubiquitination | KWKKSDVKFEDRFDK EEECCCCCHHHHHHH | 48.29 | - | |
| 210 | Ubiquitination | KFEDRFDKYLDPSFF CHHHHHHHHCCHHHH | 45.03 | 21890473 | |
| 210 | 2-Hydroxyisobutyrylation | KFEDRFDKYLDPSFF CHHHHHHHHCCHHHH | 45.03 | - | |
| 210 | Ubiquitination | KFEDRFDKYLDPSFF CHHHHHHHHCCHHHH | 45.03 | 21890473 | |
| 252 | Phosphorylation | MRTLRKDYARYSKEE HHHHHHHHHHHCCHH | 8.94 | 26074081 | |
| 255 | Phosphorylation | LRKDYARYSKEEEMD HHHHHHHHCCHHHHC | 18.87 | 26074081 | |
| 256 | Phosphorylation | RKDYARYSKEEEMDD HHHHHHHCCHHHHCC | 28.21 | 26074081 | |
| 257 | Ubiquitination | KDYARYSKEEEMDDM HHHHHHCCHHHHCCC | 61.28 | 21890473 | |
| 266 | Methylation | EEMDDMDRDLGDEYG HHHCCCCCCCHHHCC | 34.12 | 115917229 | |
| 272 | Phosphorylation | DRDLGDEYGWKQVHG CCCCHHHCCCCCCCC | 32.78 | 26074081 | |
| 419 | N-linked_Glycosylation | VGTILGRNLSGQPNF HHHHHCCCCCCCCCC | 36.44 | UniProtKB CARBOHYD | |
| 441 | Ubiquitination | PRPIPEKKWFMEPAV CCCCCCCCCCCCCHH | 43.96 | - | |
| 544 | Phosphorylation | YFFKTKMYGLFQTSF HHHHHHHHCCCCHHH | 16.54 | 23401153 | |
| 549 | Phosphorylation | KMYGLFQTSFYFGYM HHHCCCCHHHHHHHH | 17.30 | 23401153 | |
| 550 | Phosphorylation | MYGLFQTSFYFGYMA HHCCCCHHHHHHHHH | 13.73 | 23401153 | |
| 552 | Phosphorylation | GLFQTSFYFGYMAVF CCCCHHHHHHHHHHH | 8.89 | 23401153 | |
| 555 | Phosphorylation | QTSFYFGYMAVFSTA CHHHHHHHHHHHHHH | 3.36 | 23401153 | |
| 560 | Phosphorylation | FGYMAVFSTALGIMC HHHHHHHHHHHHHHH | 13.23 | 23403867 | |
| 575 | Phosphorylation | GAIGYMGTSAFVRKI HHHHHHCHHHHHHHH | 10.60 | 23401153 | |
| 576 | Phosphorylation | AIGYMGTSAFVRKIY HHHHHCHHHHHHHHH | 17.61 | 23403867 | |
| 587 | Ubiquitination | RKIYTNVKID----- HHHHHCCCCC----- | 43.13 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TM9S3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TM9S3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TM9S3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| STOM_HUMAN | STOM | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| N-linked Glycosylation | |
| Reference | PubMed |
| "Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins."; Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,Schiess R., Aebersold R., Watts J.D.; Nat. Biotechnol. 27:378-386(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-174, AND MASSSPECTROMETRY. | |
| "Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-174, AND MASSSPECTROMETRY. | |